AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10898689
Drug: Stavudine dosage
RxNorm normalized name: Stavudine
DrugBank: Stavudine (DB00649)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stavudine dosage recommendations for renal impairment (for subjects weighing <60 kg)
Trial: 8836274
Drug: Topical lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lignocaine 40 mg/ml (4 ml, < or = 3 mg/kg)
Trial: 8836274
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline (4 ml)
Trial: 1417068
Drug: Fish-oil supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil supplements over a 4-week period
Trial: 6239884
Drug: Ibuprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600 mg) + Tetracycline (250 mg) four times daily
Trial: 6239884
Drug: Ibuprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600 mg) + Placebo four times daily
Trial: 6239884
Drug: Tetracycline (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline (250 mg) + Placebo four times daily
Trial: 6239884
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Placebo four times daily
Trial: 23577062
Drug: Biojector® 2000™
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biojector® 2000™ delivery of DNA vaccine (VRC-HIVDNA016-00-VP)
Trial: 23577062
Drug: Needle and
RxNorm normalized name: syringe with needle and cannula, disposable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle and syringe (N/S) delivery of DNA vaccine (VRC-HIVDNA016-00-VP)
Trial: 16686722
Drug: Open-label solifenacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label solifenacin treatment
Trial: 11344197
Drug: ovine corticotropin-releasing
RxNorm normalized name: Ovine corticotropin-releasing factor
DrugBank: Corticorelin ovine triflutate (DB09067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ovine corticotropin-releasing hormone (oCRH)
Trial: 7974297
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (4 x 8 mg/day)
Trial: 29429455
Drug: Rehabilitation intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rehabilitation intervention (early rehabilitation including oral sensory and muscle strength training, pressure touching of head, chest, abdomen, extremities, hands, and feet)
Trial: 23153049
Drug: Straight injection
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Straight injection (SI)
Trial: 23153049
Drug: Oblique injection
RxNorm normalized name: Inonotus obliquus fruiting body
DrugBank: Inonotus obliquus fruiting body (DB14332)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oblique injection (OI)
Trial: 23153049
Drug: Double-plane tunnel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-plane tunnel injection (DPTI)
Trial: 15815120
Drug: Beta blocker
RxNorm normalized name: Beta blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blocker intervention (n=124)
Trial: 11752510
Drug: Willow bark
RxNorm normalized name: Willow bark
DrugBank: Willow bark (DB14691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Willow bark extract (Assalix) - 240 mg of salicin daily
Trial: 11752510
Drug: Rofecoxib -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib - 12.5 mg daily
Trial: 3240887
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g oxytetracycline hydrochloride
Trial: 29898671
Drug: Sit-to-stand exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sit-to-stand exercise performed at four occasions daily and a protein-rich oral supplement, twice a day for 12 weeks.
Trial: 25115659
Drug: Intrusion force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrusion force of 60 g applied for 21 days on experimental group premolars
Trial: 22261129
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of misoprostol (400 μg every 6 hours, up to 4 doses)
Trial: 22261129
Drug: Misoprostol plus
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol plus oxytocin (initial 600 μg vaginal misoprostol followed by intravenous oxytocin)
Trial: 20309628
Drug: Cyclophosphamide-containing adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide-containing adjuvant chemotherapy
Trial: 12076912
Drug: Radiofrequency ablation
RxNorm normalized name: phenylephrine hydrochloride Ophthalmic Solution [AK-Dilate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency ablation + 20 mg IV doxorubicin (Doxil) 24 hr before ablation
Trial: 8583136
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha 2b therapy at a dose of 5 MU administered daily until a response was achieved (minimum 6 months or maximum 1 year).
Trial: 2654215
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid cream applied twice daily until clearing was achieved
Trial: 2654215
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied twice daily until clearing was achieved
Trial: 116053
Drug: Irrigor (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irrigor (30 to 150 mg daily, administered in tablets, intramuscularly, and intravenously)
Trial: 116053
Drug: Irrigor (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irrigor (administered in courses, single intravenous infusion, double blind method)
Trial: 116053
Drug: Irrigor (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irrigor (administered intramuscularly and intravenously)
Trial: 31090434
Drug: Xiaoaiping injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaoaiping injections (1 dose/day for 10 days) with chemotherapy
Trial: 28437787
Drug: 0.6 mL∙kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mL∙kg‐1 of 0.25% levobupivacaine
Trial: 28437787
Drug: 0.8 mL∙kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mL∙kg‐1 of 0.25% levobupivacaine
Trial: 28437787
Drug: 1.0 mL∙kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mL∙kg‐1 of 0.25% levobupivacaine
Trial: 21323688
Drug: Dried plums
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dried plums (50 g b.d., fibre=6 gm/day)
Trial: 21323688
Drug: Psyllium (11
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (11 g b.d., fibre=6 gm/day)
Trial: 10618942
Drug: Esmolol 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol 80 mg i.v.
Trial: 1742224
Drug: Batanopride (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Batanopride (0.2 to 6.0 mg/kg)
Trial: 1742224
Drug: Batanopride (highest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Batanopride (highest dose group)
Trial: 1742224
Drug: Methylprednisolone (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (250 mg)
Trial: 7178821
Drug: Chenodeoxycholic acid
RxNorm normalized name: Chenodeoxycholic acid
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chenodeoxycholic acid (CDCA) 1000 mg/day
Trial: 7178821
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 1000 mg/day
Trial: 16943370
Drug: Rizatriptan 5
RxNorm normalized name: rizatriptan 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rizatriptan 5 mg (for body weight 20 to 39 kg)
Trial: 16943370
Drug: Rizatriptan 10
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rizatriptan 10 mg (for body weight 40 kg or more)
Trial: 2856893
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oral nadolol o.d.
Trial: 2856893
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg oral nadolol o.d.
Trial: 2856893
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg oral nadolol o.d.
Trial: 2856893
Drug: 0.25% topical
RxNorm normalized name: Remyda, 0.25% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% topical timolol b.d.
Trial: 2856893
Drug: 0.5% topical
RxNorm normalized name: Carac 0.5% Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% topical timolol b.d.
Trial: 2856893
Drug: Oral nadolol
RxNorm normalized name: Nadolol
DrugBank: Nadolol (DB01203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nadolol (various doses)
Trial: 2856893
Drug: Long-term therapy
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term therapy with oral nadolol
Trial: 29895289
Drug: Continuous IV
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous IV morphine
Trial: 24179986
Drug: Rocatec group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocatec group (Rocatec treatment and silane application)
Trial: 24179986
Drug: Ultrasonic-Rocatec group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasonic-Rocatec group (Rocatec treatment followed by ultrasonic cleaning and silanization)
Trial: 23245940
Drug: Essex cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essex cream
Trial: 17768173
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (Ciclosporin + Prednisolone)
Trial: 12454761
Drug: Fulvestrant 125
RxNorm normalized name: fulvestrant 125 MG per 2.5 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulvestrant 125 mg
Trial: 10379016
Drug: Soybean oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil diet (0.5 g trans fatty acid per 100 g fat)
Trial: 10379016
Drug: Semiliquid margarine
RxNorm normalized name: MARGARINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semiliquid margarine diet (0.5 g trans fatty acid per 100 g fat)
Trial: 10379016
Drug: Soft margarine
RxNorm normalized name: Soft margarine not polyunsaturated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft margarine diet (7.4 g trans fatty acid per 100 g fat)
Trial: 10379016
Drug: Shortening diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shortening diet (9.9 g trans fatty acid per 100 g fat)
Trial: 10379016
Drug: Stick margarine
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stick margarine diet (20.1 g trans fatty acid per 100 g fat)
Trial: 2282972
Drug: Sultamicillin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sultamicillin (50 mg/kg.day or 500 mg/day)
Trial: 2282972
Drug: Amoxycillin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (40 mg/kg.day or 250 mg/day)
Trial: 6815695
Drug: IV L-tryptophan
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV L-tryptophan (TRP)
Trial: 31551370
Drug: BCG and
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG and oral polio vaccine (OPV) administered at a single home visit
Trial: 22154318
Drug: In-treatment heart
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment heart rate (HR)
Trial: 22154318
Drug: In-treatment HR
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-treatment HR of ≥84 beats/min
Trial: 19670055
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy plus risperidone (CogTher + Risp)
Trial: 19670055
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy plus placebo (CogTher + Placebo)
Trial: 17138722
Drug: ID fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ID fat infusion with orlistat (120 mg)
Trial: 15200654
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg x kg(‐1) morphine hydrochloride (M)
Trial: 15200654
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg x kg(‐1) tramadol hydrochloride (T)
Trial: 15200654
Drug: 0.5 mg.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg.kg(‐1) ketamine hydrochloride (K)
Trial: 10063567
Drug: 5-year treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-year treatment with tamoxifen
Trial: 10063567
Drug: Systemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic therapy added to local treatment of isolated locoregional recurrence
Trial: 7970004
Drug: Lamotrigine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (200 to 500 mg daily, with higher dosages up to 700 mg in extension studies)
Trial: 4947832
Drug: Aluminium-phosphate-adsorbed tetanus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminium-phosphate-adsorbed tetanus toxoid (1-3 injections of 1 ml)
Trial: 29145711
Drug: Prehospital antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prehospital antibiotic administration by paramedics
Trial: 29145711
Drug: Delayed antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed antibiotic therapy
Trial: 27149935
Drug: L-DOPA, specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-DOPA, specific dosage and duration not mentioned
Trial: 22185955
Drug: Chiropractic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic treatment (spinal manipulation) for 4 weeks
Trial: 10827386
Drug: Conservative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative therapy after fibrinolytic therapy
Trial: 9395034
Drug: Study S8600
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Study S8600 (age < 50 years, standard dose cytarabine)
Trial: 9395034
Drug: Study S8600
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Study S8600 (age < 50 years, high dose cytarabine)
Trial: 8383390
Drug: Immune serum
RxNorm normalized name: IMMUNE SERUMS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune serum globulin (Ig) 0.06 ml/kg
Trial: 8383390
Drug: Inactivated hepatitis
RxNorm normalized name: Inactivated hepatitis A vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated hepatitis A virus vaccine (iHAV) single dose 25 ng
Trial: 8383390
Drug: Inactivated hepatitis
RxNorm normalized name: Inactivated hepatitis A vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated hepatitis A virus vaccine (iHAV) booster dose
Trial: 3769702
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg after each meal and at bedtime (200 mg qid)
Trial: 3769702
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg after breakfast and at bedtime (400 mg bid)
Trial: 3052675
Drug: Infiltration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration of lignocaine solution
Trial: 24725373
Drug: Bronchodilator use
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilator use (salbutamol)
Trial: 1817055
Drug: Initial periodontal
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial periodontal therapy consisting of a single subgingival root debridement procedure followed by repeated monthly subgingival irrigations over a period of 6 months
Trial: 22315807
Drug: Electro acupuncture
RxNorm normalized name: ELECTRODE SPRAY,ELECTRO MIST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electro acupuncture therapy (10 sittings on alternate days at GB and UB points)
Trial: 22315807
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug therapy (oral Valdecoxib) with supervised physiotherapy
Trial: 18445172
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous infusion of insulin aspart
Trial: 18445172
Drug: Insulin injection
RxNorm normalized name: diluent for insulin lispro and regular insulin INJECTION VIAL (ML)
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin injection of insulin glargine
Trial: 16941338
Drug: Highly active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly active antiretroviral therapy (HAART) for 24 weeks
Trial: 14622632
Drug: Individualised fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised fluid prescription (30 ml/kg body weight/24 h, max 35 ml/kg body weight/24 h)
Trial: 14622632
Drug: Standard fluid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fluid intake (maximum 1.5 l)
Trial: 29602346
Drug: Grafted facemask
RxNorm normalized name: polyvinyl alcohol graft polyethylene glycol copolymer (3:1; 45000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grafted facemask therapy
Trial: 29602346
Drug: Ungrafted facemask
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ungrafted facemask therapy
Trial: 29602346
Drug: Facemask therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Facemask therapy (grafted and ungrafted)
Trial: 27195774
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (FCM) with erythropoietin (EPO) - 1 g IV FCM plus 40,000 IU subcutaneous EPO
Trial: 27195774
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (FCM) without erythropoietin (EPO) - 1 g IV FCM plus subcutaneous placebo
Trial: 27195774
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - IV and subcutaneous placebo
Trial: 23077155
Drug: Oral steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroid for 10 days (group I)
Trial: 23077155
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone injection (ITDI) 4 times (group II)
Trial: 23077155
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oral steroid and ITDI (group III)
Trial: 17994222
Drug: Routine prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine prescription of daily CXRs
Trial: 17994222
Drug: Restrictive prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive prescription of clinically indicated CXRs
Trial: 12802024
Drug: Increased-dose BEACOPP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased-dose BEACOPP
Trial: 9616817
Drug: Epinephrine nebulization
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine nebulization at 5 mg (A5)
Trial: 9616817
Drug: Salbutamol nebulization
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol nebulization at 5 mg (S)
Trial: 9616817
Drug: Epinephrine nebulization
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine nebulization at 2 mg (A2)
Trial: 3935372
Drug: NORPLANT (six
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NORPLANT (six capsules)
Trial: 27123784
Drug: Atorvastatin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin plus Metformin (20 mg atorvastatin daily plus 500 mg metformin twice daily)
Trial: 27123784
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (20 mg atorvastatin daily)
Trial: 18725614
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of oral anticoagulant therapy after 6 months
Trial: 18725614
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant therapy (5-7 months after initiation)
Trial: 15920039
Drug: Current therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current therapy (two or three shots per day using NPH insulin and rapid-acting analog)
Trial: 12885745
Drug: Simvastatin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (5 mg/d increased to 10 mg/d after 4 weeks)